UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063707
Receipt number R000072902
Scientific Title Effects of bedtime intake of taxifolin-containing tablets on oral microbiota
Date of disclosure of the study information 2026/11/20
Last modified on 2026/11/20 14:47:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of bedtime intake of taxifolin-containing tablets on oral microbiota

Acronym

Effects of bedtime intake of taxifolin-containing tablets on oral microbiota

Scientific Title

Effects of bedtime intake of taxifolin-containing tablets on oral microbiota

Scientific Title:Acronym

Effects of bedtime intake of taxifolin-containing tablets on oral microbiota

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the effect of bedtime intake of taxifolin-containing tablets on salivary microbiota overnight until the next morning.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Nocturnal Changes in the Salivary Microbiome (16S rRNA Gene Analysis, V3-V4 Region)

Key secondary outcomes

Alpha diversity (e.g., Shannon index),
Beta diversity (e.g., UniFrac distance),
Proportion of periodontal disease-related bacteria (e.g., Porphyromonas, Tannerella, Treponema, Fusobacterium),
Proportion of dental caries-related bacteria (e.g., Streptococcus mutans group, Lactobacillus),
Subjective oral symptom questionnaire (stickiness in the morning, awareness of bad breath, dry mouth)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake 1 tablet (once a day) of the test food before bedtime (single intake).

Interventions/Control_2

Intake 1 tablet (once a day) of the placebo food before bedtime (single intake).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2)Persons who are healthy males and females aged 40 years old or more and 60 years old or less
3)Persons who have 20 or more of their own teeth

Key exclusion criteria

1)Persons who have chronic illness, receiving medication, have a serious disease history
2)Persons who are allergic to the test food
3)Persons who usually take a large amount of test food
4)Persons who usually take medicine, functional foods for health uses (specified health foods, functional foods, and functional nutrition foods) that may have effect to salivary microbiota
5)Persons who regularly use mouthwash and cannot stop using it
6)Persons who are undergoing dental treatment, have been diagnosed with severe periodontal disease, or use dentures (removable dentures)
7)Persons who are smokers
8)Persons who have used antibacterial or antifungal drugs within 1 month prior to the start of the study
9)Persons who have participated in other studies within the first month before the start of the study, or those who intend to participate in another study after consenting to this study
10)Persons who were judged as inappropriate for study participants by the principal investigator
11)Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Takumi
Middle name
Last name Tochio

Organization

Biosis Lab Co., Ltd.

Division name

President and CEO

Zip code

470-1192

Address

11-506, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN

TEL

090-6904-6772

Email

takumitochiobiz@gmail.com


Public contact

Name of contact person

1st name Takumi
Middle name
Last name Tochio

Organization

Biosis Lab Co., Ltd.

Division name

President and CEO

Zip code

470-1192

Address

11-506, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN

TEL

090-6904-6772

Homepage URL


Email

takumitochiobiz@gmail.com


Sponsor or person

Institute

Biosis Lab Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

SANOH CORPORATION Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 11 Month 19 Day

Date of IRB

2026 Year 11 Month 19 Day

Anticipated trial start date

2026 Year 11 Month 21 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 20 Day

Last modified on

2026 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072902